Search results
Results from the WOW.Com Content Network
By the end of December 2021, 758,891 doses had been administered and 583,609 persons (25% of the targeted population) were fully vaccinated. By the end of March 2022, 818,931 doses had been administered and 640,464 persons were fully vaccinated. By the end of April 2022, 831,318 doses had been administered and 652,422 persons were fully vaccinated.
COVAX began distributing vaccines in February 2021. Though COVAX promised 100 million doses by the end of March, [3] [4] this goal was not reached until 6 July. [5] By mid-August 2021, COVAX delivered 200 million vaccine doses to nearly 140 countries instead of the 600 million doses initially projected.
Global vaccine sharing scheme COVAX plans to ship enough COVID-19 shots to cover around 3% of the populations of low-income countries in the first half of this year, a World Health Organization ...
In November 2021, Moderna CEO Stéphane Bancel claimed that the company had a backlog of tens of millions of doses of its vaccine destined for Africa because COVAX or individual governments could not take delivery. He cited delays with dose administration, a shortage of refrigerator space, and delays getting customs documents.
The US delivers Pfizer COVID-19 vaccines to South Africa as part of the COVAX initiative in 2021. South Africa has so far paid R283 million ($20 million) to the organization in December 2020. COVAX has delivered 1.4 million doses of the Pfizer–BioNTech vaccine to the country on 28 June 2021. [67] [68]
In March 2021, Johnson & Johnson and Aspen Pharmacare made a deal to manufacture 220 million vaccines at Aspen's Gqeberha facility in Eastern Cape, South Africa. They plan to distribute the vaccine to other countries, mainly in Africa, and also through the COVID-19 Vaccines Global Access (COVAX) program. [73] [74] [75]
On 24 February 2021, a shipment of 600,000 Oxford–AstraZeneca COVID-19 vaccine to Accra via COVAX made it the first country in Africa to receive vaccines via the initiative. [5] The vaccination campaign began on 1 March 2021 as president Akufo-Addo received the first jab.
Phases 2 and 3 clinical trials of COVAX-19 are being conducted in Iran under a co-operation agreement. [8] Phase 2 clinical trials started in May 2021 and Phase 3 trials commenced in August 2021. In the phase 2 trials, 400 Iranian volunteers were injected with either a placebo or the first dose of the vaccine.